Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3653) 3653
Newsletter (162) 162
Book Chapter (99) 99
Newspaper Article (19) 19
Magazine Article (8) 8
Book / eBook (2) 2
Dissertation (2) 2
Government Document (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3027) 3027
science & technology (2811) 2811
life sciences & biomedicine (2721) 2721
epstein-barr virus (2114) 2114
male (1478) 1478
female (1377) 1377
epstein-barr virus infections - complications (955) 955
adult (941) 941
biological and medical sciences (872) 872
middle aged (871) 871
medical sciences (850) 850
health aspects (794) 794
oncology (768) 768
epstein-barr virus infections - drug therapy (561) 561
epstein-barr virus infections - virology (552) 552
hematology (542) 542
infectious diseases (541) 541
aged (528) 528
cancer (519) 519
transplantation (513) 513
adolescent (507) 507
herpesvirus 4, human - isolation & purification (505) 505
child (496) 496
epstein–barr virus (491) 491
herpesvirus 4, human - genetics (476) 476
immunology (469) 469
research (456) 456
viruses (439) 439
lymphoma (423) 423
epstein-barr virus infections - diagnosis (403) 403
risk factors (399) 399
epstein-barr virus infections - immunology (390) 390
treatment outcome (374) 374
hemic and lymphatic diseases (365) 365
care and treatment (359) 359
child, preschool (345) 345
infections (345) 345
virus diseases (341) 341
tumors (340) 340
herpesvirus 4, human - immunology (339) 339
animals (334) 334
epstein-barr virus infections - pathology (333) 333
viral diseases (324) 324
hematologic and hematopoietic diseases (320) 320
antiviral agents - therapeutic use (301) 301
prognosis (300) 300
immunotherapy (292) 292
pediatrics (290) 290
herpesvirus 4, human (287) 287
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (286) 286
lymphoproliferative disorders - virology (282) 282
herpesvirus 4, human - physiology (280) 280
lymphomas (274) 274
t cells (269) 269
pathology (265) 265
chemotherapy (261) 261
analysis (260) 260
cytomegalovirus (260) 260
young adult (259) 259
lymphoproliferative disorders - etiology (258) 258
rituximab (252) 252
medical research (245) 245
antineoplastic combined chemotherapy protocols - therapeutic use (244) 244
ebv (241) 241
abridged index medicus (238) 238
microbiology (237) 237
immunosuppressive agents - therapeutic use (234) 234
infant (230) 230
virology (226) 226
medicine & public health (219) 219
polymerase chain reaction (219) 219
surgery (218) 218
retrospective studies (216) 216
proteins (215) 215
viral load (211) 211
lymphocytes (205) 205
drug therapy (199) 199
immunosuppressive agents - adverse effects (199) 199
nasopharyngeal carcinoma (197) 197
apoptosis (191) 191
gene expression (191) 191
herpesvirus 4, human - drug effects (186) 186
immunocompromised host (186) 186
diagnosis (185) 185
fatal outcome (185) 185
herpesvirus 4, human - pathogenicity (183) 183
pharmacology. drug treatments (183) 183
epstein‐barr virus (178) 178
patients (178) 178
biopsy (177) 177
immunohistochemistry (176) 176
epstein-barr virus infections - etiology (175) 175
genetic aspects (174) 174
lymphoproliferative disorders - drug therapy (173) 173
human viral diseases (172) 172
antiviral agents (171) 171
development and progression (170) 170
immunosuppression (170) 170
epstein-barr virus infections - therapy (169) 169
antigens (168) 168
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3843) 3843
Japanese (36) 36
French (30) 30
Russian (22) 22
Chinese (20) 20
German (20) 20
Spanish (19) 19
Portuguese (7) 7
Polish (5) 5
Italian (3) 3
Serbian (3) 3
Danish (2) 2
Czech (1) 1
Dutch (1) 1
Korean (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Asymptomatic CMV replication during early Human Immunodeficiency Virus (HIV) infection is associated with lower CD4/CD8 ratio during HIV treatment
by Smith, Davey M and Nakazawa, Masato and Freeman, Michael L and Anderson, Christy M and Oliveira, Michelli F and Little, Susan J and Gianella, Sara
Clinical infectious diseases, ISSN 1058-4838, 2016, Volume 63, Issue 11, pp. 1517 - 1524
Cytomegalovirus | Epstein-Barr virus | ART | HIV | CD4/CD8 ratio | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Herpesvirus 4, Human - genetics | Humans | Male | Cytomegalovirus Infections - complications | Cytomegalovirus Infections - immunology | Viral Load | Asymptomatic Infections | HIV Infections - immunology | CD4-CD8 Ratio | HIV-1 - isolation & purification | Cytomegalovirus Infections - virology | Adult | Epstein-Barr Virus Infections - blood | Cytomegalovirus - physiology | Cytomegalovirus - genetics | HIV Seropositivity | Epstein-Barr Virus Infections - immunology | HIV Infections - virology | Herpesvirus 4, Human - physiology | Herpesvirus 4, Human - immunology | Antiretroviral Therapy, Highly Active | DNA, Viral - blood | Regression Analysis | HIV-1 - immunology | Virus Replication | Bayes Theorem | HIV Infections - complications | HIV Infections - drug therapy | Complications and side effects | Antiviral agents | CD4 lymphocytes | Analysis | Cytomegalovirus infections | Dosage and administration | Drug therapy | HIV infection | Risk factors | Antiretroviral drugs | Regression analysis | Human immunodeficiency virus--HIV | Herpes viruses | Index Medicus | CD4 | cytomegalovirus | CD8 ratio | AIDS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
by Philippe, Michael and Ranchon, Florence and Gilis, Lila and Schwiertz, Vérane and Vantard, Nicolas and Ader, Florence and Labussiere-Wallet, Hélène and Thomas, Xavier and Nicolini, Franck-Emmanuel and Wattel, Eric and Ducastelle-Leprêtre, Sophie and Barraco, Fiorenza and Lebras, Laure and Salles, Gilles and Michallet, Mauricette and Rioufol, Catherine
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 723 - 730
Hematology, Oncology and Palliative Medicine | Cidofovir | BK virus | Hemorrhagic cystitis | Hematopoietic stem cell transplantation | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic Neoplasms - therapy | Myeloablative Agonists - therapeutic use | Polyomavirus Infections - immunology | Cytosine - analogs & derivatives | Polyomavirus Infections - etiology | BK Virus - drug effects | Hematologic Neoplasms - mortality | Humans | Middle Aged | Hemorrhage - mortality | Cystitis - immunology | Male | Hematologic Neoplasms - pathology | Transplantation, Homologous | Hemorrhage - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Tumor Virus Infections - immunology | Tumor Virus Infections - therapy | Adult | Female | Cytosine - therapeutic use | Retrospective Studies | Cystitis - etiology | Glomerular Filtration Rate | Drug Administration Schedule | Organophosphonates - therapeutic use | Antiviral Agents - therapeutic use | Hemorrhage - therapy | Hemorrhage - immunology | Cystitis - therapy | Graft Survival | Tumor Virus Infections - mortality | Cystitis - mortality | Polyomavirus Infections - mortality | Polyomavirus Infections - therapy | Survival Analysis | Hematologic Neoplasms - immunology | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Tumor Virus Infections - etiology | Viral Load - drug effects | BK Virus - physiology | Care and treatment | Cystitis | Hematopoietic stem cells | Stem cells | Medical research | Leptin | Medicine, Experimental | Epstein-Barr virus | Index Medicus | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus—Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
by Jan Styczynski and Lidia Gil and Gloria Tridello and Per Ljungman and J. Peter Donnelly and Walter van der Velden and Hamdy Omar and Rodrigo Martino and Constantijn Halkes and Maura Faraci and Koen Theunissen and Krzysztof Kalwak and Petr Hubacek and Simona Sica and Chiara Nozzoli and Franca Fagioli and Susanne Matthes and Miguel A. Diaz and Maddalena Migliavacca and Adriana Balduzzi and Agnieszka Tomaszewska and Rafael de la Camara and Anja van Biezen and Jennifer Hoek and Simona Iacobelli and Hermann Einsele and Simone Cesaro and Infect Dis Working Party European and Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Clinical infectious diseases, ISSN 1058-4838, 9/2013, Volume 57, Issue 6, pp. 794 - 802
Health outcomes | Immunosuppression | Lymphoproliferative disorders | Mortality | Predisposing factors | Viral diseases | Transplantation | Graft vs host disease | Epstein Barr virus infections | ARTICLES AND COMMENTARIES | Blood | hematopoietic stem cell transplantation | risk factors | Epstein-Barr virus | post-transplant lymphoproliferative disorder | prognostic model | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hematologic and hematopoietic diseases | Infectious diseases | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Immunomodulators | Prognosis | Humans | Middle Aged | Child, Preschool | Infant | Epstein-Barr Virus Infections - surgery | Viral Load | Herpesvirus 4, Human - isolation & purification | Adult | Retrospective Studies | Child | Epstein-Barr Virus Infections - epidemiology | Lymphoproliferative Disorders - surgery | Epstein-Barr Virus Infections - virology | Lymphoproliferative Disorders - virology | Risk Factors | Kaplan-Meier Estimate | Europe - epidemiology | Hematopoietic Stem Cell Transplantation | Rituximab | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - epidemiology | DNA, Viral - blood | Adolescent | Lymphoproliferative Disorders - drug therapy | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Prescription drugs | Hematology | Stem cells | Drug therapy | Multivariate analysis | Blood diseases | Risk factors | Clinical outcomes | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cordycepin enhances Epstein–Barr virus lytic infection and Epstein–Barr virus-positive tumor treatment efficacy by doxorubicin
by Du, Yinping and Yu, Jieshi and Du, Li and Tang, Jun and Feng, Wen-Hai
Cancer letters, ISSN 0304-3835, 2016, Volume 376, Issue 2, pp. 240 - 248
Hematology, Oncology and Palliative Medicine | EBV-associated tumors | Doxorubicin | Epstein–Barr virus | Cordycepin | Epstein-Barr virus | Life Sciences & Biomedicine | Oncology | Science & Technology | Phosphorylation | Antibiotics, Antineoplastic - pharmacology | Humans | Herpesvirus 4, Human - drug effects | Stomach Neoplasms - metabolism | Oncolytic Viruses - pathogenicity | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Transfection | RNA Interference | Time Factors | Protein Kinase C - metabolism | Herpesvirus 4, Human - pathogenicity | Oncolytic Viruses - drug effects | p38 Mitogen-Activated Protein Kinases - metabolism | Stomach Neoplasms - genetics | Stomach Neoplasms - virology | CCAAT-Enhancer-Binding Protein-beta - genetics | Stomach Neoplasms - therapy | Mice, SCID | CCAAT-Enhancer-Binding Protein-beta - metabolism | Oncolytic Virotherapy | Xenograft Model Antitumor Assays | Animals | Virus Activation - drug effects | Signal Transduction - drug effects | Tumor Burden - drug effects | Cell Line, Tumor | Deoxyadenosines - pharmacology | Doxorubicin - pharmacology | Anthracyclines | Drug therapy | Health aspects | Tumors | Chemotherapy | Microbiology | Lymphomas | Mitogens | Protein kinases | Cancer | Protein binding | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Role of viral infections in the development and exacerbation of asthma in children
by Jartti, Tuomas and Gern, James E
Journal of allergy and clinical immunology, ISSN 0091-6749, 10/2017, Volume 140, Issue 4, pp. 895 - 906
wheeze | wheezing | respiratory syncytial virus | rhinovirus | virus | bronchiolitis | Asthma | child | exacerbation | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Microbiota - immunology | Virus Diseases - immunology | Humans | Palivizumab - therapeutic use | Respiratory Syncytial Viruses - immunology | Virulence | Rhinovirus - pathogenicity | Risk | Asthma - drug therapy | Disease Progression | Bronchiolitis | Animals | Virus Diseases - drug therapy | Asthma - immunology | Anti-Inflammatory Agents - therapeutic use | Respiratory Sounds | Rhinovirus - immunology | Child | Respiratory Syncytial Viruses - pathogenicity | Development and progression | Virulence (Microbiology) | Asthma in children | Risk factors | Medical colleges | Nerve growth factor | Epstein-Barr virus | Bronchopneumonia | Wheezing | Viruses | Infections | Vaccines | Respiratory tract | Copyright | Airway management | Illnesses | Vitamin D | Virulence factors | Genetics | Accreditation | Children | Age | Hypersensitivity | Inflammation | Environmental factors | Risk analysis | Health education | Allergies | Structural damage | Monoclonal antibodies | Nitrogen dioxide | Viral infections | Index Medicus | Abridged Index Medicus | RV, Rhinovirus | TLR, Toll-like receptor | nBreg, Neonatal regulatory B | OR, Odds ratio | CDHR3, Cadherin-related family member 3 | NGF, Nerve growth factor | RSV, Respiratory syncytial virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Autoimmune disease: A role for new anti-viral therapies?
by Dreyfus, David H
Autoimmunity reviews, ISSN 1568-9972, 2011, Volume 11, Issue 2, pp. 88 - 97
Allergy and Immunology | HIV-1 | HERV | Systemic Lupus Erythematosus | Immunopathology | RNAi | Multiple sclerosis | Rheumatoid Arthritis | Chronic autoimmune urticaria | RNAse P EGS | Vaccines | XLP | Epstein–Barr Virus Infection | Epstein-Barr Virus Infection | Life Sciences & Biomedicine | Immunology | Science & Technology | RNA, Small Interfering - genetics | Urticaria - virology | Herpesvirus 4, Human - genetics | Viral Vaccines - therapeutic use | Lymphoproliferative Disorders | Humans | Urticaria - genetics | Vaccination | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Herpesvirus 4, Human - drug effects | Autoimmunity - genetics | Multiple Sclerosis - prevention & control | Immunologic Memory - drug effects | Epstein-Barr Virus Infections - prevention & control | Endogenous Retroviruses - metabolism | Autoimmunity - immunology | Lupus Erythematosus, Systemic - drug therapy | Lupus Erythematosus, Systemic - immunology | B-Lymphocytes - virology | Epstein-Barr Virus Infections - genetics | Lupus Erythematosus, Systemic - prevention & control | Integrase Inhibitors | Raltegravir Potassium | Epstein-Barr Virus Infections - virology | Antiviral Agents - therapeutic use | Epstein-Barr Virus Infections - immunology | Lupus Erythematosus, Systemic - virology | Multiple Sclerosis - virology | RNA, Small Interfering - pharmacology | Herpesvirus 4, Human - immunology | Rituximab | Multiple Sclerosis - genetics | Endogenous Retroviruses - drug effects | Urticaria - immunology | Epstein-Barr Virus Infections - drug therapy | Viral Vaccines - administration & dosage | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Pyrrolidinones | Urticaria - drug therapy | Lupus Erythematosus, Systemic - genetics | Multiple Sclerosis - immunology | Endogenous Retroviruses - immunology | Chronic Disease | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Multiple Sclerosis - drug therapy | Lupus | Autoimmunity | Antiviral agents | RNA | Genes | Arthritis | Ribonuclease | HIV (Viruses) | Virus diseases | Rheumatoid factor | Monoclonal antibodies | Epstein-Barr virus | Autoimmune diseases | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disorder
by Green, M and Michaels, M. G
American journal of transplantation, ISSN 1600-6135, 02/2013, Volume 13, Issue s3, pp. 41 - 54
posttransplant lymphoproliferative disorder | malignancy | organ transplantation | Epstein–Barr virus | Epstein-Barr virus | Malignancy | Organ transplantation | Posttransplant lymphoproliferative disorder | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Antiviral Agents - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Lymphoproliferative Disorders - complications | Treatment Outcome | Antigens, CD20 - metabolism | Postoperative Complications - diagnosis | Viral Load | Incidence | Immunoglobulins, Intravenous - metabolism | Animals | Lymphoproliferative Disorders - diagnosis | Transplantation - adverse effects | Interferons - metabolism | Adult | Epstein-Barr Virus Infections - complications | Mice | Antibodies, Monoclonal - metabolism | Herpesvirus 4, Human - metabolism | Child | Epstein-Barr Virus Infections - epidemiology | Virus diseases | Monoclonal antibodies | Transplantation of organs, tissues, etc | Health aspects | Immunotherapy | Drug therapy | Medical research | Index Medicus | Chemotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights